Delivery Order SPE2DB20D2104-SPE2DB24FR37W
- Not listed
- The U.S. government awarded a $16,371.45 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Trelegy Ellipta 100-62.5-25 60S medication. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of April 26, 2023. This award is associated with AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The U.S. government has awarded a Delivery Order contract valued at $20,600.23 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Trelegy Ellipta 100-62.5-25 60S medication. The contract is administered by the Defense Logistics Agency (DLA) Troop Support Medical, which is responsible for supplying medical products to federal agencies. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides Trelegy Ellipta 200-62.5-25 60S medication to the Defense Logistics Agency (DLA). The contract, valued at $9,647.31, is a delivery order with a firm fixed price. The award has an ultimate completion date of June 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
- This federal contract award, valued at $12,141.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the medication Trelegy Ellipta 100-62.5-25 60S, with a completion date of April 24, 2025. The contract is a firm fixed-price, non-set-aside agreement. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The contract, valued at $25,100.02, was awarded by the Defense Logistics Agency (DLA) on February 7, 2023, with a completion date of February 8, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The $77,568.28 firm-fixed-price delivery order contract has an ultimate completion date of August 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 medication in 60-count units. The $29,677.67 Firm Fixed Price delivery order contract has an ultimate completion date of April 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award is for $3,151.57 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Trelegy Ellipta 100-62.5-25 60S medication. The contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 25, 2024. The contract is a firm fixed-price arrangement with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,460.94 firm-fixed-price delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $34,089.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR37WDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $19,321.26 for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The contract, a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, has a firm fixed price and an ultimate completion date of November 30, 2023. The DLA, a defense agency, awarded this contract to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company, Cencora, Inc., holds a $999,999,999 IDC with the DLA Troop Support Medical through 2026, providing a comprehensive range of essential pharmaceutical products and medical supplies to the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 11/29/23 |